Ketorolac versus nepafenac in cataract surgery.
McCulley
James P
JP
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects; D044482:Benzeneacetamides / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D020911:Ketorolac Tromethamine / Q000008:administration & dosage* / Q000009:adverse effects; D007903:Lens Capsule, Crystalline / Q000187:drug effects; D019654:Lens Implantation, Intraocular; D009883:Ophthalmic Solutions / Q000008:administration & dosage / Q000009:adverse effects; D010149:Postoperative Pain / Q000517:prevention & control*; D010349:Patient Compliance; D017060:Patient Satisfaction; D018918:Phacoemulsification; D010648:Phenylacetates / Q000008:administration & dosage* / Q000009:adverse effects; D014606:Uveitis, Anterior / Q000517:prevention & control*; D014792:Visual Acuity / Q000187:drug effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D044482:Benzeneacetamides; D009883:Ophthalmic Solutions; D010648:Phenylacetates; C414203:nepafenac; D020911:Ketorolac Tromethamine